49 The influence of cytogenetic abnormalities on treatment outcome after intensive antileukemic therapy for patients with high risk MDS

Authors :: P. Weijermans
M. Dardenne
Boris Labar
Ulrich Jehn
Franco Mandelli
Carlo Aul
Eric Archimbaud
Marc Boogaerts
A. Gratwohl
S. Amadori
J. F. Apperley
P. Muus
Stefan Suciu
Hilde Demuynck
T. de Witte
Augustin Ferrant
D Selleslag
Roelof Willemze
Source :: Leukemia Research. 21:S13
Publication Year :: 1997
Publisher :: Elsevier BV, 1997.

Subjects :: Cancer Research
medicine.medical_specialty
Oncology
business.industry
Internal medicine
Treatment outcome
Medicine
Hematology
business

Tools